Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Return on Equity (2016 - 2025)

Vanda Pharmaceuticals' Return on Equity history spans 15 years, with the latest figure at 0.01% for Q4 2025.

  • On a quarterly basis, Return on Equity fell 1.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 1.0% decrease, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Equity hit 0.01% in Q4 2025 for Vanda Pharmaceuticals, down from 0.0% in the prior quarter.
  • Over the last five years, Return on Equity for VNDA hit a ceiling of 0.0% in Q3 2021 and a floor of 0.01% in Q4 2025.
  • Historically, Return on Equity has averaged 0.0% across 5 years, with a median of 0.0% in 2022.
  • Biggest five-year swings in Return on Equity: changed 0bps in 2021 and later decreased -1bps in 2025.
  • Tracing VNDA's Return on Equity over 5 years: stood at 0.0% in 2021, then tumbled by -82bps to 0.0% in 2022, then crashed by -62bps to 0.0% in 2023, then tumbled by -867bps to 0.0% in 2024, then plummeted by -1490bps to 0.01% in 2025.
  • Business Quant data shows Return on Equity for VNDA at 0.01% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.